Nosiheptide

CAS No. 56377-79-8

Nosiheptide( Multhiomycin | RP 9671 )

Catalog No. M24551 CAS No. 56377-79-8

Nosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 126 In Stock
10MG 216 In Stock
25MG 378 In Stock
50MG 561 In Stock
100MG 798 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nosiheptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Nosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus.
  • Description
    Nosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus. Nosiheptide has been widely used as a feed additive for animal growth. Nosiheptide inhibits bacterial protein synthesis and bears a unique indole side ring system and regiospecific hydroxyl groups on the characteristic macrocyclic core.
  • In Vitro
    Nosiheptide exhibits extremely potent activity against all contemporary Staphylococcus aureus strains tested including multiple drug-resistant clinical isolates, with MIC values ≤ 0.25 mg/L. Nosiheptide is also highly active against Enterococcus spp and the contemporary hypervirulent BI strain of Clostridium difficile but is inactive against most Gram-negative strains tested. Time-kill analysis reveals Nosiheptide to be rapidly bactericidal against Staphylococcus aureus in a concentration- and time-dependent manner, with a nearly 2-log kill noted at 6 hours at 10X MIC. Furthermore, Nosiheptide is found to be non-cytotoxic against mammalian cells at >> 100X MIC, and its anti-Staphylococcus aureus activity is not inhibited by 20% human serum. Notably, Nosiheptide exhibits a significantly prolonged post-antibiotic effect against both healthcare- and community-associated Staphylococcus aureus compared to vancomycin.
  • In Vivo
    Nosiheptide (20 mg/kg; intraperitoneal injection; injected at 1 and 8 h post-infection; female CD1 mice) provids significant protection against mortality. Ten out of 10 of the Nosiheptide-treated mice remains alive on day 3, while 6/10 of the controls died on day 1. Animal Model:Eight week old female CD1 mice injected with HA-Staphylococcus aureus strain Sanger 252 Dosage:20 mg/kg Administration:Intraperitoneal injection; injected at 1 and 8 h post-infection Result:Provided significant protection against mortality.
  • Synonyms
    Multhiomycin | RP 9671
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Antibiotic|Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56377-79-8
  • Formula Weight
    1222.36
  • Molecular Formula
    C51H43N13O12S6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (102.26 mM; Need ultrasonic)
  • SMILES
    OC1=C(C2=NC(C(NC(C(N)=O)=C)=O)=CS2)N=C(C3=CSC(C4NC(C5=CSC(C(CC(C(OCC6=C7C(C)=C(NC7=CC=C6)C(SC4)=O)=O)O)NC(C8=CSC(/C(NC(C(C(O)C)NC(C9=CSC%10=N9)=O)=O)=C\C)=N8)=O)=N5)=O)=N3)C%10=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Haste NM, et al. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2012 Dec;65(12):593-8.
molnova catalog
related products
  • Silver sulfadiazine

    It is a topical antibiotic used in partial thickness and full thickness burns to prevent infection.

  • Cephalexin monohydra...

    Cephalexin monohydrate (Cephalexin hydrate) is an orally available semi-synthetic cephalosporin antibiotic with significant antimicrobial activity that inhibits bacterial proliferation by targeting penicillin-binding proteins (PBPs).

  • (S)-5-chloro-N-(1-((...

    (S)-5-chloro-N-(1-((4-chlorophenyl)amino)-1-oxo-3-phenylpropan-2-yl)-2-hydroxybenzamide has antifungal and tuberculostatic activities.